Market Trends of Global Ureteral Stent Industry
This section covers the major market trends shaping the Ureteral Stents Market according to our research experts:
Urinary Tract Infection Segment is Expected to Exibhit a Significant Growth Rate in the Ureteral Stent Market
The urinary tract infection segment is expected to exhibit significant growth in the ureteral stents market, owing to a higher incidence of urinary tract infection, kidney and bladder diseases, and higher adoption of ureteral stents. For instance, as per International Agency for Research on Cancer, the estimated number of people with bladder cancer is likely to be 7,356,11 by 2030. Furthermore, as per the same source, the mortality relating to bladder cancer is expected to be 2,861,64 by 2030. Since the anticipated number of cancers relating to the bladder is higher there is likely to be more adoption of ureteral stents and thus boosting the market growth.
The presence of competitors, research initiatives, and government funding fuels market growth. For instance, an article published in 2022 under the title 'Allium Ureteral Stent as a Treatment for Ureteral Stricture: Results and Concerns', stated that 'Allium URS' is likely to be considered a feasible and attractive treatment of ureteral strictures, due to its minimal invasiveness and it is best suited for the older population.
Because of the aforementioned factors, the total urinary tract infection segment is likely to face growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global ureteral stent market due to the growing burden of diseases related to the kidney. According to the Center for Disease Control and Prevention data in 2021, in the United States, nearly 1 in 3 people with diabetes and 1 in 5 people with high blood pressure have kidney disease. Furthermore, despite the prevalence of kidney disease in the United States, as many as 9 in 10 people who have CKD are not aware they have the disease. Thus, the rising prevalence of chronic kidney disease is expected to be a major contributor to the ureteral stents market in this region.
Increased research and development in the field of ureteral stent boost the market growth. For instance, an article published in 2022 under the title 'Design of a fully intraureteral stent and proof-of-concept in vivo evaluation', special focus has been given to new coated and biodegradable ureteral stent designs. To lessen tissue irritation, these stents work to decrease inflammatory processes and microbial adherence to the stent.
As per the factors mentioned above, North America is expected to witness growth over the forecast period.
